カテゴリー： QYResearch, 世界

世界の勃起不全（ED）薬市場 2019年

【英語タイトル】Global Erectile Dysfunction(ED) Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X07425）・商品コード：DATA909X07425
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：103
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：材料・化学
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、勃起不全（ED）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、バルデナフィル、アバナフィル、タダラフィル、バルデナフィルに、用途別には、スーパーマーケット、オンラインストア、薬局、その他にセグメント区分し、勃起不全（ED）薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・勃起不全（ED）薬の世界市場概要
・勃起不全（ED）薬の製造コスト構成分析
・勃起不全（ED）薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・勃起不全（ED）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・勃起不全（ED）薬のセグメント分析（種類別）
（バルデナフィル、アバナフィル、タダラフィル、バルデナフィル）
・勃起不全（ED）薬のセグメント分析（用途別）
（スーパーマーケット、オンラインストア、薬局、その他）
・勃起不全（ED）薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Pfizer、Lilly、Bayer、Johnson & Johnson、Baiyunshan Pharmaceutical Company、Cipla、）
・勃起不全（ED）薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Erectile Dysfunction(ED) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Erectile Dysfunction(ED) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Erectile Dysfunction(ED) Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Erectile Dysfunction(ED) Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Erectile Dysfunction(ED) Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Lilly
Bayer
Johnson & Johnson
Baiyunshan Pharmaceutical Company
Cipla
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Vardenafil
Avanafil
Tadalafil
Vardenafil

Segment by Application
Supermarket
Online Store
Pharmacy
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Erectile Dysfunction(ED) Drug
1.1 Definition of Erectile Dysfunction(ED) Drug
1.2 Erectile Dysfunction(ED) Drug Segment by Type
1.2.1 Global Erectile Dysfunction(ED) Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Vardenafil
1.2.3 Avanafil
1.2.4 Tadalafil
1.2.5 Vardenafil
1.3 Erectile Dysfunction(ED) Drug Segment by Applications
1.3.1 Global Erectile Dysfunction(ED) Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Supermarket
1.3.3 Online Store
1.3.4 Pharmacy
1.3.5 Other
1.4 Global Erectile Dysfunction(ED) Drug Overall Market
1.4.1 Global Erectile Dysfunction(ED) Drug Revenue (2014-2025)
1.4.2 Global Erectile Dysfunction(ED) Drug Production (2014-2025)
1.4.3 North America Erectile Dysfunction(ED) Drug Status and Prospect (2014-2025)
1.4.4 Europe Erectile Dysfunction(ED) Drug Status and Prospect (2014-2025)
1.4.5 China Erectile Dysfunction(ED) Drug Status and Prospect (2014-2025)
1.4.6 Japan Erectile Dysfunction(ED) Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Erectile Dysfunction(ED) Drug Status and Prospect (2014-2025)
1.4.8 India Erectile Dysfunction(ED) Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Erectile Dysfunction(ED) Drug
2.3 Manufacturing Process Analysis of Erectile Dysfunction(ED) Drug
2.4 Industry Chain Structure of Erectile Dysfunction(ED) Drug

3 Development and Manufacturing Plants Analysis of Erectile Dysfunction(ED) Drug
3.1 Capacity and Commercial Production Date
3.2 Global Erectile Dysfunction(ED) Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Erectile Dysfunction(ED) Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Erectile Dysfunction(ED) Drug Production and Capacity Analysis
4.2 Erectile Dysfunction(ED) Drug Revenue Analysis
4.3 Erectile Dysfunction(ED) Drug Price Analysis
4.4 Market Concentration Degree

5 Erectile Dysfunction(ED) Drug Regional Market Analysis
5.1 Erectile Dysfunction(ED) Drug Production by Regions
5.1.1 Global Erectile Dysfunction(ED) Drug Production by Regions
5.1.2 Global Erectile Dysfunction(ED) Drug Revenue by Regions
5.2 Erectile Dysfunction(ED) Drug Consumption by Regions
5.3 North America Erectile Dysfunction(ED) Drug Market Analysis
5.3.1 North America Erectile Dysfunction(ED) Drug Production
5.3.2 North America Erectile Dysfunction(ED) Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Erectile Dysfunction(ED) Drug Import and Export
5.4 Europe Erectile Dysfunction(ED) Drug Market Analysis
5.4.1 Europe Erectile Dysfunction(ED) Drug Production
5.4.2 Europe Erectile Dysfunction(ED) Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Erectile Dysfunction(ED) Drug Import and Export
5.5 China Erectile Dysfunction(ED) Drug Market Analysis
5.5.1 China Erectile Dysfunction(ED) Drug Production
5.5.2 China Erectile Dysfunction(ED) Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Erectile Dysfunction(ED) Drug Import and Export
5.6 Japan Erectile Dysfunction(ED) Drug Market Analysis
5.6.1 Japan Erectile Dysfunction(ED) Drug Production
5.6.2 Japan Erectile Dysfunction(ED) Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Erectile Dysfunction(ED) Drug Import and Export
5.7 Southeast Asia Erectile Dysfunction(ED) Drug Market Analysis
5.7.1 Southeast Asia Erectile Dysfunction(ED) Drug Production
5.7.2 Southeast Asia Erectile Dysfunction(ED) Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Erectile Dysfunction(ED) Drug Import and Export
5.8 India Erectile Dysfunction(ED) Drug Market Analysis
5.8.1 India Erectile Dysfunction(ED) Drug Production
5.8.2 India Erectile Dysfunction(ED) Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Erectile Dysfunction(ED) Drug Import and Export

6 Erectile Dysfunction(ED) Drug Segment Market Analysis (by Type)
6.1 Global Erectile Dysfunction(ED) Drug Production by Type
6.2 Global Erectile Dysfunction(ED) Drug Revenue by Type
6.3 Erectile Dysfunction(ED) Drug Price by Type

7 Erectile Dysfunction(ED) Drug Segment Market Analysis (by Application)
7.1 Global Erectile Dysfunction(ED) Drug Consumption by Application
7.2 Global Erectile Dysfunction(ED) Drug Consumption Market Share by Application (2014-2019)

8 Erectile Dysfunction(ED) Drug Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Erectile Dysfunction(ED) Drug Production Sites and Area Served
8.1.2 Pfizer Product Introduction, Application and Specification
8.1.3 Pfizer Erectile Dysfunction(ED) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Lilly
8.2.1 Lilly Erectile Dysfunction(ED) Drug Production Sites and Area Served
8.2.2 Lilly Product Introduction, Application and Specification
8.2.3 Lilly Erectile Dysfunction(ED) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bayer
8.3.1 Bayer Erectile Dysfunction(ED) Drug Production Sites and Area Served
8.3.2 Bayer Product Introduction, Application and Specification
8.3.3 Bayer Erectile Dysfunction(ED) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Johnson & Johnson
8.4.1 Johnson & Johnson Erectile Dysfunction(ED) Drug Production Sites and Area Served
8.4.2 Johnson & Johnson Product Introduction, Application and Specification
8.4.3 Johnson & Johnson Erectile Dysfunction(ED) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Baiyunshan Pharmaceutical Company
8.5.1 Baiyunshan Pharmaceutical Company Erectile Dysfunction(ED) Drug Production Sites and Area Served
8.5.2 Baiyunshan Pharmaceutical Company Product Introduction, Application and Specification
8.5.3 Baiyunshan Pharmaceutical Company Erectile Dysfunction(ED) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Cipla
8.6.1 Cipla Erectile Dysfunction(ED) Drug Production Sites and Area Served
8.6.2 Cipla Product Introduction, Application and Specification
8.6.3 Cipla Erectile Dysfunction(ED) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served

9 Development Trend of Analysis of Erectile Dysfunction(ED) Drug Market
9.1 Global Erectile Dysfunction(ED) Drug Market Trend Analysis
9.1.1 Global Erectile Dysfunction(ED) Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Erectile Dysfunction(ED) Drug Regional Market Trend
9.2.1 North America Erectile Dysfunction(ED) Drug Forecast 2019-2025
9.2.2 Europe Erectile Dysfunction(ED) Drug Forecast 2019-2025
9.2.3 China Erectile Dysfunction(ED) Drug Forecast 2019-2025
9.2.4 Japan Erectile Dysfunction(ED) Drug Forecast 2019-2025
9.2.5 Southeast Asia Erectile Dysfunction(ED) Drug Forecast 2019-2025
9.2.6 India Erectile Dysfunction(ED) Drug Forecast 2019-2025
9.3 Erectile Dysfunction(ED) Drug Market Trend (Product Type)
9.4 Erectile Dysfunction(ED) Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Erectile Dysfunction(ED) Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Erectile Dysfunction(ED) Drug
Table Global Erectile Dysfunction(ED) Drug Production (Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Erectile Dysfunction(ED) Drug Production Market Share by Types in 2018
Figure Vardenafil Product Picture
Figure Avanafil Product Picture
Figure Tadalafil Product Picture
Figure Vardenafil Product Picture
Table Global Erectile Dysfunction(ED) Drug Consumption (Units) Comparison by Applications (2014-2025)
Figure Global Erectile Dysfunction(ED) Drug Consumption Market Share by Applications in 2018
Figure Supermarket
Figure Online Store
Figure Pharmacy
Figure Other
Figure Global Erectile Dysfunction(ED) Drug Revenue (Million USD) (2014-2025)
Figure Global Erectile Dysfunction(ED) Drug Production (Units) (2014-2025)
Figure North America Erectile Dysfunction(ED) Drug Market Size (Million USD) (2014-2025)
Figure Europe Erectile Dysfunction(ED) Drug Market Size (Million USD) (2014-2025)
Figure China Erectile Dysfunction(ED) Drug Market Size (Million USD) (2014-2025)
Figure Japan Erectile Dysfunction(ED) Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Erectile Dysfunction(ED) Drug Market Size (Million USD) (2014-2025)
Figure India Erectile Dysfunction(ED) Drug Market Size (Million USD) (2014-2025)
Table Erectile Dysfunction(ED) Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Erectile Dysfunction(ED) Drug in 2018
Figure Manufacturing Process Analysis of Erectile Dysfunction(ED) Drug
Figure Industry Chain Structure of Erectile Dysfunction(ED) Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Erectile Dysfunction(ED) Drug Manufacturing Plants Distribution
Table Erectile Dysfunction(ED) Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Erectile Dysfunction(ED) Drug Capacity (Units) of Major Manufacturers (2014-2019)
Table Erectile Dysfunction(ED) Drug Production (Units) of Major Manufacturers (2014-2019)
Table Erectile Dysfunction(ED) Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Erectile Dysfunction(ED) Drug Production Share by Manufacturers in 2018
Table Erectile Dysfunction(ED) Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Erectile Dysfunction(ED) Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Erectile Dysfunction(ED) Drug Revenue Share by Manufacturers in 2018
Table Erectile Dysfunction(ED) Drug Average Price (K USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Erectile Dysfunction(ED) Drug Production by Regions 2014-2019 (Units)
Table Global Erectile Dysfunction(ED) Drug Production Market Share by Regions 2014-2019
Figure Global Erectile Dysfunction(ED) Drug Production Market Share by Regions in 2018
Table Global Erectile Dysfunction(ED) Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Erectile Dysfunction(ED) Drug Revenue Market Share by Regions 2014-2019
Figure Global Erectile Dysfunction(ED) Drug Revenue Market Share by Regions in 2018
Table Global Erectile Dysfunction(ED) Drug Consumption by Regions 2014-2019 (Units)
Table Global Erectile Dysfunction(ED) Drug Consumption Market Share by Regions 2014-2019
Figure North America Erectile Dysfunction(ED) Drug Production Growth Rate 2014-2019 (Units)
Figure North America Erectile Dysfunction(ED) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Erectile Dysfunction(ED) Drug Production, Consumption Import and Export (Units)
Figure Europe Erectile Dysfunction(ED) Drug Production Growth Rate 2014-2019 (Units)
Figure Europe Erectile Dysfunction(ED) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Erectile Dysfunction(ED) Drug Production, Consumption Import and Export (Units)
Figure China Erectile Dysfunction(ED) Drug Production Growth Rate 2014-2019 (Units)
Figure China Erectile Dysfunction(ED) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Erectile Dysfunction(ED) Drug Production, Consumption Import and Export (Units)
Figure Japan Erectile Dysfunction(ED) Drug Production Growth Rate 2014-2019 (Units)
Figure Japan Erectile Dysfunction(ED) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Erectile Dysfunction(ED) Drug Production, Consumption Import and Export (Units)
Figure Southeast Asia Erectile Dysfunction(ED) Drug Production Growth Rate 2014-2019 (Units)
Figure Southeast Asia Erectile Dysfunction(ED) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Erectile Dysfunction(ED) Drug Production, Consumption Import and Export (Units)
Figure India Erectile Dysfunction(ED) Drug Production Growth Rate 2014-2019 (Units)
Figure India Erectile Dysfunction(ED) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Erectile Dysfunction(ED) Drug Production, Consumption Import and Export (Units)
Figure Global Consumption Erectile Dysfunction(ED) Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Erectile Dysfunction(ED) Drug Market Share by Application (2014-2019)
Table Pfizer Erectile Dysfunction(ED) Drug Production Sites and Area Served
Table Pfizer Erectile Dysfunction(ED) Drug Product Introduction, Application and Specification
Table Pfizer Erectile Dysfunction(ED) Drug Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Erectile Dysfunction(ED) Drug Production Growth Rate (2014-2019)
Table Pfizer Erectile Dysfunction(ED) Drug Production Market Share (2014-2019)
Figure Pfizer Erectile Dysfunction(ED) Drug Revenue Market Share (2014-2019)
Table Pfizer Erectile Dysfunction(ED) Drug Main Business and Markets Served
Table Lilly Erectile Dysfunction(ED) Drug Production Sites and Area Served
Table Lilly Erectile Dysfunction(ED) Drug Product Introduction, Application and Specification
Table Lilly Erectile Dysfunction(ED) Drug Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Lilly Erectile Dysfunction(ED) Drug Production Growth Rate (2014-2019)
Table Lilly Erectile Dysfunction(ED) Drug Production Market Share (2014-2019)
Figure Lilly Erectile Dysfunction(ED) Drug Revenue Market Share (2014-2019)
Table Lilly Erectile Dysfunction(ED) Drug Main Business and Markets Served
Table Bayer Erectile Dysfunction(ED) Drug Production Sites and Area Served
Table Bayer Erectile Dysfunction(ED) Drug Product Introduction, Application and Specification
Table Bayer Erectile Dysfunction(ED) Drug Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Bayer Erectile Dysfunction(ED) Drug Production Growth Rate (2014-2019)
Table Bayer Erectile Dysfunction(ED) Drug Production Market Share (2014-2019)
Figure Bayer Erectile Dysfunction(ED) Drug Revenue Market Share (2014-2019)
Table Bayer Erectile Dysfunction(ED) Drug Main Business and Markets Served
Table Johnson & Johnson Erectile Dysfunction(ED) Drug Production Sites and Area Served
Table Johnson & Johnson Erectile Dysfunction(ED) Drug Product Introduction, Application and Specification
Table Johnson & Johnson Erectile Dysfunction(ED) Drug Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Erectile Dysfunction(ED) Drug Production Growth Rate (2014-2019)
Table Johnson & Johnson Erectile Dysfunction(ED) Drug Production Market Share (2014-2019)
Figure Johnson & Johnson Erectile Dysfunction(ED) Drug Revenue Market Share (2014-2019)
Table Johnson & Johnson Erectile Dysfunction(ED) Drug Main Business and Markets Served
Table Baiyunshan Pharmaceutical Company Erectile Dysfunction(ED) Drug Production Sites and Area Served
Table Baiyunshan Pharmaceutical Company Erectile Dysfunction(ED) Drug Product Introduction, Application and Specification
Table Baiyunshan Pharmaceutical Company Erectile Dysfunction(ED) Drug Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Baiyunshan Pharmaceutical Company Erectile Dysfunction(ED) Drug Production Growth Rate (2014-2019)
Table Baiyunshan Pharmaceutical Company Erectile Dysfunction(ED) Drug Production Market Share (2014-2019)
Figure Baiyunshan Pharmaceutical Company Erectile Dysfunction(ED) Drug Revenue Market Share (2014-2019)
Table Baiyunshan Pharmaceutical Company Erectile Dysfunction(ED) Drug Main Business and Markets Served
Table Cipla Erectile Dysfunction(ED) Drug Production Sites and Area Served
Table Cipla Erectile Dysfunction(ED) Drug Product Introduction, Application and Specification
Table Cipla Erectile Dysfunction(ED) Drug Production (Units), Revenue (Million USD), Ex-factory Price (K USD/Unit) and Gross Margin (2014-2019)
Table Cipla Erectile Dysfunction(ED) Drug Production Growth Rate (2014-2019)
Table Cipla Erectile Dysfunction(ED) Drug Production Market Share (2014-2019)
Figure Cipla Erectile Dysfunction(ED) Drug Revenue Market Share (2014-2019)
Table Cipla Erectile Dysfunction(ED) Drug Main Business and Markets Served
Figure Global Erectile Dysfunction(ED) Drug Production (Units) Growth Rate Forecast 2019-2025
Figure Global Erectile Dysfunction(ED) Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Erectile Dysfunction(ED) Drug Sales Price (K USD/Unit) Forecast 2019-2025
Figure North America Erectile Dysfunction(ED) Drug Production Growth Rate Forecast 2019-2025 (Units)
Figure North America Erectile Dysfunction(ED) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Erectile Dysfunction(ED) Drug Production Growth Rate Forecast 2019-2025 (Units)
Figure Europe Erectile Dysfunction(ED) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Erectile Dysfunction(ED) Drug Production Growth Rate Forecast 2019-2025 (Units)
Figure China Erectile Dysfunction(ED) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Erectile Dysfunction(ED) Drug Production Growth Rate Forecast 2019-2025 (Units)
Figure Japan Erectile Dysfunction(ED) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Erectile Dysfunction(ED) Drug Production Growth Rate Forecast 2019-2025 (Units)
Figure Southeast Asia Erectile Dysfunction(ED) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Erectile Dysfunction(ED) Drug Production Growth Rate Forecast 2019-2025 (Units)
Figure India Erectile Dysfunction(ED) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (Units) of Erectile Dysfunction(ED) Drug by Type (2019-2025)
Table Global Consumption (Units) of Erectile Dysfunction(ED) Drug by Application (2019-2025)
Table Erectile Dysfunction(ED) Drug Distributors List
Table Erectile Dysfunction(ED) Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Pfizer、Lilly、Bayer、Johnson & Johnson、Baiyunshan Pharmaceutical Company、Cipla、

★調査レポート[世界の勃起不全（ED）薬市場 2019年] (コード：DATA909X07425)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の勃起不全（ED）薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 女性用性機能障害治療の世界市場：規模・現状・予測2019-2025
    DATA909X18465 / QYResearch / 2019年11月25日 / ※当調査レポートでは、女性用性機能障害治療の世界市場について調査・分析し、女性用性機能障害治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（非ホルモン療法、ホルモン療法）、用途別（性的欲求障害、性的興奮障害、オルガスム障害、性的疼痛障害、オルガスム後疾患、骨盤底機能障害、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の女性用性機能障害治療市場動向 ・主要企業別マーケットシェア ・女性用性機能障害治療の種類別市場規模2014-2019 （非ホルモン療法、ホルモン療法） ・女性用性機能障害治療の用途別市場規模2014-2019 （性的欲求障害、性的興奮障害、オルガスム障害、性的疼痛障害、オルガスム後疾患、骨盤底機能障害、その他） ・女性用性機能障害治療の北米市場：主要企業・種類別/用途別市場規模 ・女性用性機能障害治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market during the forecast period. Women suffering from chronic health conditions such as diabetes may also be diagnosed with sexual dysfunction. Clinical indications, including hypertension, obesity, metabolic syndrome, and atherogenic dyslipidemia, of chronic conditions such as diabetes, are the risk factors for sexual dysfunctions in women. The rising prevalence of chronic health conditions in...
  • 世界の動脈血栓症薬市場 2019年
    DATA909X03729 / QYResearch / 2019年11月15日 / ※本調査レポートは、動脈血栓症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AS-1468240、ASP-6537、BAY-1213790、BMS-65445、その他に、用途別には、クリニック、病院、その他にセグメント区分し、動脈血栓症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・動脈血栓症薬の世界市場概要 ・動脈血栓症薬の製造コスト構成分析 ・動脈血栓症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・動脈血栓症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・動脈血栓症薬のセグメント分析（種類別） （AS-1468240、ASP-6537、BAY-1213790、BMS-65445、その他）...The global Arterial Thrombosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Arterial Thrombosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Arterial Thrombosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Arterial Thrombosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のOTC薬市場 2019年
    DATA909X12465 / QYResearch / 2019年11月20日 / ※本調査レポートは、OTC薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、クラスA、クラスBに、用途別には、病院、クリニック、家庭にセグメント区分し、OTC薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・OTC薬の世界市場概要 ・OTC薬の製造コスト構成分析 ・OTC薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・OTC薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・OTC薬のセグメント分析（種類別） （クラスA、クラスB）...The global OTC Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on OTC Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall OTC Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of OTC Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their OTC Drug manufacturing...
  • 世界のライノウイルス感染薬市場 2019年
    DATA909X14407 / QYResearch / 2019年11月20日 / ※本調査レポートは、ライノウイルス感染薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他に、用途別には、クリニック、病院、その他にセグメント区分し、ライノウイルス感染薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ライノウイルス感染薬の世界市場概要 ・ライノウイルス感染薬の製造コスト構成分析 ・ライノウイルス感染薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ライノウイルス感染薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ライノウイルス感染薬のセグメント分析（種類別） （塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他）...The global Rhinovirus Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rhinovirus Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rhinovirus Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Rhinovirus Infections Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆